ArticleBMC ophthalmology2026
Ocular structural parameters in children with attention-deficit/hyperactivity disorder: a case-control study of drug-naïve and methylphenidate-treated patients.
Article in BMC ophthalmology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThis study aimed to evaluate ocular structural parameters in children with attention-deficit/hyperactivity disorder (ADHD) and to investigate potential differences associated with Methylphenidate Hydrochloride (MPH) treatment.
methodsIn this cross-sectional case-control study, 193 children were included and divided into three groups: Group 1 comprised 56 ADHD patients receiving MPH, Group 2 included 55 drug-naïve ADHD patients, and Group 3 consisted of 82 healthy controls. All participants underwent comprehensive ophthalmologic examinations, including cycloplegic refraction, intraocular pressure (IOP), corneal topography, specular microscopy, and spectral-domain optical coherence tomography (SD-OCT). Retinal nerve fiber layer (RNFL) thickness, macular ganglion cell complex (GCC), and retinal thickness in parafoveal and perifoveal regions were analyzed.
resultsNo significant differences were observed in refraction, IOP, or corneal parameters among the three groups. OCT measurements showed that superior and inferior RNFL were significantly thinner in MPH-treated ADHD patients compared with controls (p = 0.010 and p < 0.001, respectively). Parafoveal retinal thickness, excluding the nasal quadrant, was increased in drug-naïve ADHD patients (superior p = 0.008, inferior p = 0.015, temporal p = 0.040), whereas perifoveal thickness was reduced in MPH-treated children (superior p = 0.011, inferior p = 0.014, temporal p = 0.004). No significant differences were found in GCC thickness between the groups. No significant correlation was observed between duration of MPH treatment and retinal thickness parameters (all p > 0.05).
conclusionsAnterior segment parameters were similar across groups, but retinal thickness differed between drug-naïve and MPH-treated ADHD patients, possibly related to disease characteristics or treatment effects, with no clear association with treatment duration. Prospective studies are needed to clarify these effects.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.